QualityStocks would like to highlight
MIT Holding (
OTCQB: MITD). The company, through its agents, facilitators, and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.
In the company’s news,
MIT Holding, Inc. (OTCQB: MITD), through its wholly-owned subsidiary, Medical Infusion Technologies, has been carving a niche into the ambulatory care niche since 1990. Ambulatory care is big business throughout the United States. According to CDC reports, over 136 million visits to emergency rooms and other ambulatory care providers were recorded throughout 2011. Of these visits, over 55 million, or about 40 percent, were reportedly from the southern region of the country.
Medical Infusion Technologies is a trusted provider of outpatient care services servicing a 22-county region ranging from Savannah, GA to Okatie, SC. The company’s primary services include providing ambulatory infusion therapy to patients with conditions requiring ongoing care that doesn’t, necessarily, call for recurring visits to hospitals. The company’s primary care center in Savannah offers patients access to comfortable private infusion suites and a professional medical staff to answer questions and provide needed treatments in a less strenuous environment.
In cases where intravenous medication or nutrient delivery become a recurring part of a patient’s life, the company offers home infusion training and delivery to increase convenience for patients. In this scenario, the company sends a highly trained staff member to equip the patient with the necessary knowledge and medications needed for self-administration of required, recurring medical treatments. Common types of therapies currently available for home infusion include hydration, inotropic therapy, antibiotics, antivirals, antifungals, limited chemotherapy, Synagis® and total parenteral nutrition (TPN).
Other in-home care services offered by the company include a host of perinatal services designed to limit the stresses and complications that can be associated with late-term pregnancy. Care options including pre-term labor, hyperemesis management, diabetes monitoring, hypertension treatment and coagulation disorders are potentially vital treatment capabilities provided to expectant mothers in the comfort of their own homes by MIT Holding, Inc. The company’s large delivery area and knowledgeable staff help recovering patients get the treatment and equipment needed without the stresses commonly associated with hospitals and emergency rooms. With the constantly changing landscape of the healthcare industry, continued evolution and growth initiatives will serve to validate the company’s business model into the future.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.
To sign up for The QualityStocks Daily Newsletter, please visit www.QualityStocks.net
To connect with QualityStocks via Facebook, please visit http://Facebook.com/QualityStocksPage
To connect with QualityStocks via Twitter, please visit http://Twitter.com/QualityStocks
Please read FULL disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
